ALLE
48
2
DTE
42
4
MO
57
4
NVDA
57
-2
DHI
40
3
D
45
4
JNJ
54
3
EQT
51
-5
PNW
57
2
AN
52
2
DRI
64
4
CVS
41
2
AAPL
55
2
VIX
19
-2
EQR
47
2
HRL
38
3
FSLR
60
-10
O
35
4
MSI
47
-2
C
85
3
ALLE
48
2
DTE
42
4
MO
57
4
NVDA
57
-2
DHI
40
3
D
45
4
JNJ
54
3
EQT
51
-5
PNW
57
2
AN
52
2
DRI
64
4
CVS
41
2
AAPL
55
2
VIX
19
-2
EQR
47
2
HRL
38
3
FSLR
60
-10
O
35
4
MSI
47
-2
C
85
3
Financhill
Back

NYLI Global Equity R&D Leaders ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
74

WRND
NYLI Global Equity R&D Leaders ETF

Last Price:
$36.92
Seasonality Move:
7.02%
Sell
43

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.09
Seasonality Move:
10.04%
Buy
74
NYLI Global Equity R&D Leaders ETF (WRND) is a Buy

Is NYLI Global Equity R&D Leaders ETF a Buy, Sell or Hold?

  • The current NYLI Global Equity R&D Leaders ETF [WRND] share price is $37.36. The Score for WRND is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • WRND is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.78. The Score for MNPR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WRND Stock Price Chart

What is NYLI Global Equity R&D Leaders ETF's stock price today?

  • The NYLI Global Equity R&D Leaders ETF share price today is $37.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WRND is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

WRND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.09 Buy
Relative Strength Index (14 RSI): 56.9 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.13 - 37.35) Buy
Bollinger Bands (100): (34.69 - 37.27) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.36 Sell
Relative Strength Index (14 RSI): 41.31 Sell
Chaikin Money Flow: -7995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.78 - 85.32) Sell
Bollinger Bands (100): (46.95 - 89.61) Buy

WRND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.67 Buy
20-day SMA: 36.97 Buy
50-day SMA: 36.88 Buy
200-day SMA: 33.41 Buy
8-day EMA: 26.34 Buy
20-day EMA: 14.45 Buy
50-day EMA: 6.65 Buy
200-day EMA: 1.79 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.14 Buy
20-day SMA: 75.62 Sell
50-day SMA: 80.01 Sell
200-day SMA: 52.96 Buy
8-day EMA: 71.06 Sell
20-day EMA: 74.56 Sell
50-day EMA: 76.11 Sell
200-day EMA: 57.1 Buy

NYLI Global Equity R&D Leaders ETF Earnings Growth & WRND Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

NYLI Global Equity R&D Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):